Return on Investment and Cost-Effectiveness of Harm Reduction Programme in Malaysia. Naning H, Kerr C, Kamarulzaman A, et al. (2013)

immage

This project aimed to assess whether the harm reduction programme in Malaysia, which consists of NSP and MMT programmes amongst PWID, have been cost-effective from the perspective of the government by estimating savings in direct health care cost to the government resulting from infections that were averted as a result of the NSP and MMT programmes. The following estimates were included in the estimate of savings in direct health care costs; estimate the cost-effectiveness of the NSP and MMT programmes in terms of costs for the provision of programmes net of health care cost savings for each quality-adjusted-life years (QALYs) gained; estimate the return on investment (ROI) from NSP and MMT programmes where ROI refers to total health care costs saved from averted infections in comparison to total programme costs.


Keywords: HIV, AIDS, needles, syringes, PWID, estimates, infections

Download Publication

Smart Investments. UNAIDS. (2013)

immage

HIV investment cases provide an important vehicle for countries to deliver strategic, rights-based, sustainable responses to HIV. The process of developing investment cases provides countries with new opportunities to explore options for innovative funding and service delivery, to identify specific steps to enhance equity and inclusiveness for key populations, to use available evidence to understand better the health and economic benefits of timely, rights-based, smart HIV investments and to eliminate inefficiency in HIV programmes.

Download Publication

Meeting the Investment Challenge Tipping the Dependency Balance. UNAIDS (2012)

Investment Challenge_Supplement

Shared Responsibility Mutual Accountability Global Solidarity.

Domestic investments have surpassed global giving in 2011. Low- and middle-income countries invested US$ 8.6 billion in 2011. While countries are tipping the balance, international assistance still remains critical and indispensable in the short and medium term. International assistance from donor government and philanthropies has remained stable at around US$ 8.2 billion in the past few years.

 

 

Download this publication

The Long Run Costs and Financing of HIV/AIDS in Cambodia. Saphonn V, Chhorvann C, Sopheab H, and et al (2012).

immage

The methodology for carrying out this study has centered on three elements:
- projection of the course of the epidemic under different program scale-up scenarios;
- estimating the resources required for addressing the HIV/AIDS epidemic as it unfolds according to the different scenarios; and,
- assessing how the resources required in the future might be financed

Download Publication

China National AIDS Spending Assessment 2010. Yakusik A, Zhongdan C, Fernández CA, et al. (2012)

immage

Comprehensive information about national spending on AIDS response is crucial for health policy development and evaluation. Dehong Prefecture of Yunnan Province is one of the areas hardest hit by HIV in China. Since 1989, when the first 146 HIV-infected injecting drug users (IDUs) were identified in Dehong, this area with 1.1 million of people reported a cumulative total of 17,590 HIV cases by the end of 2010. Studies conducted suggest that the population prevalence for HIV infections in Dehong Prefecture is estimated to be 1.3%. IDUs make up the majority of the people living with HIV (PLHIV) in Dehong Prefecture, accounting for more than a half of the total number of estimated HIV cases in Dehong with high estimated HIV prevalence. HIV transmission mode has been changing gradually over the recent years from intravenous drug use to heterosexual and homosexual transmission. This study provides a comprehensive overview of the overall level and composition of major investments in national AIDS response in Dehong Prefecture introducing National AIDS Spending Assessment (NASA) as a method for the purpose.


Keywords: HIV/AIDS, cases, death, mode of transmission, investments, funding

Download Publication

New Funding Model – Frequently Asked Questions. The Global Fund (2012)

New Funding_Model_FAQs_consolidated

The Global Fund needs to invest more strategically, to make the most of its resources and maximize the impact and value-for-money of its grants. This new approach, part of a broader change to a new business model, will allow the Global Fund to rebalance and manage its portfolio proactively, to focus investments on the right interventions, in the right countries and on the right populations. 

 

 

 

Download this publication

Strategic Investments for Impact: Global Fund Results Report 2012. The Global Fund (2012)

Strategic Investments_for_Impact_Global_Fund_Results_Report_2012

The Global Fund Results Report 2012 presents the latest data from recipients of Global Fund grants in 151 countries – as well as the latest evidence of impact on the HIV, tuberculosis (TB) and malaria pandemics, and the most up-to-date information on Global Fund financing. It highlights the continued progress and the scale-up achieved by low- and middle-income countries around the world, made possible by the collaboration and efforts of hundreds of governments, donors, recipients, technical agencies, private companies and civil society organizations.

 

 

 

Download this publication

Viet Nam National AIDS Spending Assessment 2008-2010. UNAIDS (2012)

VN-NASA2

This report is a compiled analysis of two National AIDS Spending Assessments (NASA) conducted in 2010 and 2011 in Viet Nam by a team of consultants hired by UNAIDS Vietnam, with the support from Viet Nam Administration of HIV/AIDS Control. The first NASA captured AIDS expenditure by nearly all national and international funding sources in Viet Nam over the two-year period 2008 to 2009, while the second NASA captured this expenditure for 2010. The two NASA track the resources of health services as well as social-mitigation, education, labour, justice and other sectors to embody the multisectoral response in Viet Nam. Through its findings, the NASA aim to inform and support the development of Viet Nam’s new National Strategy on HIV/AIDS Prevention and Control to 2020, with a vision to 2030. 

 

 

Download this publication

Indonesia National AIDS Spending Assessment 2011-2012. Nadjib M, Megraini A, Ishardini L and Rosalina L. (2013)

immage

HIV and AIDS are among health issues prioritized in the Millenium Development Goals (MDGs) and require considerable attention from various stakeholders. The Government of Indonesia, along with international partners has been working hard in suppressing the spread of AIDS in the country through various programs. However, more challenges remain, and despite considerable amount of money spent in resources to combat HIV and AIDS in Indonesia, the rate of new cases of HIV continue to persist.

 

Keywords: NASA, expenditures, spending, prevention, treatment, vulnerable

Download Publication

Expanding Long Term Financing Options for HIV in Viet Nam. UNAIDS (2012)

VN Expanding2

Vietnam has achieved considerable success in scaling up its programmatic response to address the HIV/AIDS pandemic in recent years. However while public agencies and civil society organisations have played a key role in this success, 74% of total resources have come from development partners. 

 

 

Download this publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Get_on_the_Fast-Track_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NEC_HIV_July-Oct-AIDSreg2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Response_Progress_Reporting_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_AIDS_by_the_numbers_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Biomedical_AIDS_research_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Factsheets.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_Report_Punjab_2014_0.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Integrating_collaborative_TB_and_HIV_services_within_a_comprehensive_package_of_care_for_PWID_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_IBBS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_HSS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/The_negative_impact_of_drug_control_on_public_health_2015.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_young_people_drugs_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Death_Penalty_for_Drug_Offences_Global_Overview_2015.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Transforming_our_world_2015_UN.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Consolidated_Strategic_Information_Guidelines_for_HIV_in_Health_Sector_2015.pdf
Calendar of events
May
17
(17 May - 17 May)
Jul
28
(28 Jul - 28 Jul)